½ÃÀ庸°í¼­
»óǰÄÚµå
1594697

°æ±¸ ½Ã¸°Áö ½ÃÀå : Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Oral Syringes Market by Product (Clear Oral Syringes, Colorful Oral Syringes), Usage (Disposable Oral Syringes, Reusable Oral Syringes), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 180 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°æ±¸ ½Ã¸°Áö ½ÃÀåÀº 2023³â 9¾ï 756¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³â¿¡´Â 9¾ï 6,844¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 7.19% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 14¾ï 7,588¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°æ±¸ ½Ã¸°Áö´Â ÀÇ·á ºÐ¾ß¿¡¼­ ÇʼöÀûÀÎ µµ±¸·Î, ƯÈ÷ Á¤Á¦¸¦ »ïŰ±â ¾î·Á¿î À¯¾Æ, ³ëÀÎ µî ȯÀÚ¿¡°Ô Á¤È®ÇÑ ¾çÀÇ ¾×ü ¾à¹°À» Åõ¿©ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ±¸°­ ÁÖ»ç±âÀÇ Çʿ伺Àº Á¤È®ÇÑ Åõ¾à, Åõ¾à ½Ç¼ö¸¦ ÁÙÀ̰í ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½ÃŰ´Â µ¥ ÀÖ½À´Ï´Ù. °æ±¸ ½Ã¸°Áö´Â ÁÖ·Î º´¿ø, Áø·á¼Ò ¹× ÀçÅà °£È£ ÇöÀå¿¡¼­ »ç¿ëµÇ¸ç ¾à»ç, °£È£»ç ¹× °£º´ÀÎÀÌ ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚÀÔ´Ï´Ù. °æ±¸ ½Ã¸°Áö ½ÃÀåÀº ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, Àα¸ °í·ÉÈ­, ¼Ò¾Æ ¹× ³ëÀÎ ÀÇ·á ¼­ºñ½º ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀο¡ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅà ÀÇ·á Æ®·»µå¿Í ȯÀÚ Áß½ÉÀÇ Á¢±Ù ¹æ½ÄÀº »ç¿ëÇϱ⠽±°í Á¤È®ÇÑ Åõ¾à ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ȯ°æ ģȭÀûÀÎ BPA ÇÁ¸® ÁÖ»ç±â, ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ´Â ÀÎü°øÇÐÀû µðÀÚÀÎ °³¹ß µî Àç·á ±â¼úÀÇ Çõ½ÅÀº Á¦Á¶¾÷ü¿¡ Å« ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿øÀÚÀç °¡°Ý º¯µ¿, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, µµÂ¡ ÄŰú °°Àº ´ëüǰÀÇ Á¸Àç¿Í °°Àº ¹®Á¦´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ À庮À¸·Î ÀÎÇØ Á¦Ç° Ãâ½Ã°¡ Áö¿¬µÇ°í Á¦Á¶¾÷üÀÇ ÄÄÇöóÀ̾𽺠ºñ¿ëÀÌ Áõ°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¼ú Çõ½ÅÀÇ ±âȸ´Â ¼øÀÀµµ ÃßÀû ¹× Åõ¾à ¾Ë¸²À» À§ÇÑ Ä¿³ØÆ¼µå ±â´ÉÀ» Á¦°øÇÏ´Â ½º¸¶Æ® ÁÖ»ç±â¿Í °°Àº µðÁöÅÐ ÅëÇÕ°ú ºñ¿ë È¿À²ÀûÀÎ ÀÏȸ¿ë ÁÖ»ç±â Á¦Á¶¸¦ À§ÇÑ Á¦Á¶ ±â¼úÀÇ ¹ßÀü¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷µéÀº Áö¼Ó°¡´É¼º°ú ȯÀÚ Âü¿©¸¦ Áß½ÃÇÏ´Â Æ®·»µå¿¡ ºÎÇÕÇÏ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç, Á¦Ç° Â÷º°È­¸¦ À§ÇØ ÁÖ¿ä ±â¾÷µé °£ÀÇ °æÀïÀÌ Ä¡¿­ÇÕ´Ï´Ù. ½ÅÈï ½ÃÀå¿¡ ÁýÁßÇϰí À¯Åë¸ÁÀ» È®ÀåÇÔÀ¸·Î½á ±â¾÷Àº ½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ °­È­ÇÏ°í °³ÀÎÈ­µÈ ÀÇ·á Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 9¾ï 756¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 9¾ï 6,844¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 14¾ï 7,588¸¸ ´Þ·¯
CAGR(%) 7.19%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â °æ±¸ ½Ã¸°Áö ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°æ±¸ ½Ã¸°Áö ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ¿µÀ¯¾Æ¿Í ³ë¾àÀÚÀÇ °æ±¸¾à Åõ¿©ÀÇ Çʿ伺
    • ¿Ü°ú ¼ö¼ú Áõ°¡
    • ÀÏȸ¿ë ±¸°­ ÁÖ»ç±âÀÇ ³ôÀº äÅ÷ü
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • °æ±¸ ½Ã¸°ÁöÀÇ ±â¼úÀû ÇѰè¿Í º¹À⼺
  • ½ÃÀå ±âȸ
    • ±â¼úÀûÀ¸·Î Áøº¸µÈ °æ±¸ ½Ã¸°Áö ¼Ò°³
    • °æ±¸ Åõ¿© ÁÖ»ç±âÀÇ Á¤È®µµ Çâ»ó
  • ½ÃÀå °úÁ¦
    • Æó±â¹° ó¸® ¹®Á¦

Porter's Five Forces : °æ±¸ ½Ã¸°Áö ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °æ±¸ ½Ã¸°Áö ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °æ±¸ ½Ã¸°Áö ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : °æ±¸ ½Ã¸°Áö ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

°æ±¸ ½Ã¸°Áö ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : °æ±¸ ½Ã¸°Áö ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â °æ±¸ ½Ã¸°Áö ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æ±¸ ½Ã¸°Áö ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

°æ±¸ ½Ã¸°Áö ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå °æ±¸ ½Ã¸°Áö ½ÃÀå : Á¦Ç°º°

  • Ŭ¸®¾î °æ±¸ ½Ã¸°Áö
  • Ä÷¯Ç® °æ±¸ ½Ã¸°Áö

Á¦7Àå °æ±¸ ½Ã¸°Áö ½ÃÀå : ¿ëµµº°

  • ÀÏȸ¿ë °æ±¸ ½Ã¸°Áö
  • Àç»ç¿ë °¡´ÉÇÑ °æ±¸ ½Ã¸°Áö

Á¦8Àå °æ±¸ ½Ã¸°Áö ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • ȨÄÉ¾î ¼³Á¤
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ °æ±¸ ½Ã¸°Áö ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æ±¸ ½Ã¸°Áö ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °æ±¸ ½Ã¸°Áö ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • 3M Company
  • AdvaCare Pharma
  • B. Braun SE
  • Becton, Dickinson and Company
  • Cadence, Inc.
  • Cardinal Health, Inc.
  • CODAN Medizinische Gerate GmbH & Co KG
  • Comar
  • Cotran Corporation
  • Gerresheimer AG
  • Medline Industries, LP
  • Medtronic PLC
  • Nipro Pharma Corporation
  • Terumo Corporation
  • The Medi-Dose Group
ksm 24.11.28

The Oral Syringes Market was valued at USD 907.56 million in 2023, expected to reach USD 968.44 million in 2024, and is projected to grow at a CAGR of 7.19%, to USD 1,475.88 million by 2030.

Oral syringes are essential tools within the healthcare sector, primarily used for delivering precise doses of liquid medications to patients, particularly infants and the elderly, who may have difficulty swallowing pills. The necessity of oral syringes lies in their ability to provide accurate dosing, reduce medication errors, and enhance patient safety. They are predominantly used in hospitals, clinics, and home care settings, with pharmacists, nurses, and caregivers being the primary end-users. The market for oral syringes is influenced by factors such as the rising prevalence of chronic diseases, an aging population, and increasing demand for pediatric and geriatric healthcare services. Additionally, the growth in home healthcare trends and patient-centric approaches are fueling the demand for user-friendly and accurate dosing solutions. Innovations in material technology, such as the development of eco-friendly and BPA-free syringes, and ergonomic designs to improve patient compliance offer significant opportunities for manufacturers. However, challenges such as fluctuating raw material prices, stringent regulatory requirements, and the presence of substitutes like dosing cups may impede market growth. Furthermore, regulatory hurdles can delay product launches and increase compliance costs for manufacturers. Opportunities for innovation lie in digital integration, such as smart syringes that provide connectivity features for tracking adherence and offering dosing reminders, as well as advancements in manufacturing techniques to produce cost-effective and disposable syringes. To capitalize on these opportunities, companies should invest in R&D to develop innovative solutions that align with the growing emphasis on sustainability and patient engagement. The market is dynamic, with a high level of competition among key players striving for product differentiation. By focusing on emerging markets and expanding distribution networks, businesses can enhance their market presence and leverage the increasing demand for personalized healthcare delivery systems.

KEY MARKET STATISTICS
Base Year [2023] USD 907.56 million
Estimated Year [2024] USD 968.44 million
Forecast Year [2030] USD 1,475.88 million
CAGR (%) 7.19%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oral Syringes Market

The Oral Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need for oral medication administration for infants and geriatric population
    • Increasing number of surgical procedures
    • High adoption of disposable oral syringes
  • Market Restraints
    • Technical limitations and complexities of oral syringes
  • Market Opportunities
    • Introduction of technologically advanced oral syringes
    • Improvements in accuracy of oral dosing syringe
  • Market Challenges
    • Issues pertaining to waste disposal

Porter's Five Forces: A Strategic Tool for Navigating the Oral Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oral Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oral Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oral Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oral Syringes Market

A detailed market share analysis in the Oral Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oral Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oral Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oral Syringes Market

A strategic analysis of the Oral Syringes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oral Syringes Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AdvaCare Pharma, B. Braun SE, Becton, Dickinson and Company, Cadence, Inc., Cardinal Health, Inc., CODAN Medizinische Gerate GmbH & Co KG, Comar, Cotran Corporation, Gerresheimer AG, Medline Industries, LP, Medtronic PLC, Nipro Pharma Corporation, Terumo Corporation, and The Medi-Dose Group.

Market Segmentation & Coverage

This research report categorizes the Oral Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Clear Oral Syringes and Colorful Oral Syringes.
  • Based on Usage, market is studied across Disposable Oral Syringes and Reusable Oral Syringes.
  • Based on End-User, market is studied across Clinics, Homecare Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for oral medication administration for infants and geriatric population
      • 5.1.1.2. Increasing number of surgical procedures
      • 5.1.1.3. High adoption of disposable oral syringes
    • 5.1.2. Restraints
      • 5.1.2.1. Technical limitations and complexities of oral syringes
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technologically advanced oral syringes
      • 5.1.3.2. Improvements in accuracy of oral dosing syringe
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to waste disposal
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oral Syringes Market, by Product

  • 6.1. Introduction
  • 6.2. Clear Oral Syringes
  • 6.3. Colorful Oral Syringes

7. Oral Syringes Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable Oral Syringes
  • 7.3. Reusable Oral Syringes

8. Oral Syringes Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Homecare Settings
  • 8.4. Hospitals

9. Americas Oral Syringes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oral Syringes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oral Syringes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. AdvaCare Pharma
  • 3. B. Braun SE
  • 4. Becton, Dickinson and Company
  • 5. Cadence, Inc.
  • 6. Cardinal Health, Inc.
  • 7. CODAN Medizinische Gerate GmbH & Co KG
  • 8. Comar
  • 9. Cotran Corporation
  • 10. Gerresheimer AG
  • 11. Medline Industries, LP
  • 12. Medtronic PLC
  • 13. Nipro Pharma Corporation
  • 14. Terumo Corporation
  • 15. The Medi-Dose Group
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦